latest news releases from the newsroom
Keller Rohrback L.L.P.
Keller Rohrback L.L.P. Announces Court Ruling That Supplemental ERISA Claims Against Merck & Co. Inc. in Relation to Its 401K Plans Should be Pursued Separately From Existing Action -- MRK
SEATTLE, June 18, 2008 (PRIME NEWSWIRE) -- Keller Rohrback L.L.P. (www.erisafraud.com), Co-Lead Counsel for the ERISA plaintiffs in the In re Merck & Co. Inc. Securities, Derivative, & ERISA Litigation, MDL No. 1658, pending in the U.S. District Court for the District of New Jersey, announces that the Court recently ruled that proposed supplemental claims related to Vytorin against Merck & Co. Inc. ("Merck" or the "Company") (NYSE:MRK) for potential violations of the Employee Retirement Income Security Act of 1974 ("ERISA") should be pursued separately from those being pursued in this action. Separate lawsuits are on file that lodge claims based upon Merck's conduct in relation to Vytorin and allege that Merck breached its ERISA-mandated fiduciary duties in relation to the investments in the Merck Common Stock Fund within the Merck & Co., Inc. Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, or the Merck Puerto Rico Employee Savings & Security Plan (collectively, the "Plans"). If you are or were a participant in the Merck & Co., Inc. Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, or the Merck Puerto Rico Employee Savings & Security Plan during the April 1, 2006 through March 31, 2008 time frame, and were invested in the Merck Common Stock Fund, and would like further information about the ERISA claims lodged against Merck in relation Vytorin, please contact paralegal Mark Gangl or attorney Amy Hanson toll free at (800) 776-6044, or via e-mail at firstname.lastname@example.org.